温脏扶正驱邪法对2型糖尿病T淋巴细胞免疫功能影响的临床研究
|
摘要
研究背景:
近年来,中医药在治疗2型糖尿病及其并发症方面逐步体现出独特的优势,特别是中药复方的多靶点作用,整体调节机体免疫,达到“扶正以祛邪,祛邪不伤正”的目的。随着人们生活水平的提高及生活方式的改变,2型糖尿病的发病率越来越高,现已成为继肿瘤及心血管疾病之后第三位导致人类死亡的疾病。中医药对于本病的临床治疗现多采用辨病与辨证相结合的方法,多以养阴清热、益气养阴、清热生津、健脾化湿及活血化瘀等为主,其作用机理与改善胰岛素抵抗、调节脂糖代谢紊乱及减少炎症反应等有关。上述研究加深了对运用中医药治疗2型糖尿病的认识,但还存在不少亟待解决的问题。本病的发生与体质、环境、生活习惯等多种因素相关,不同治法在疾病的不同阶段发挥作用,如何在治法研究中体现“辨证”的思路,有待进一步探讨。
研究目的:
临床中发现2型糖尿病患者存在明显的正气不足、阳气虚弱的特点,从六经辨证的观点来看,以三阴病本,兼夹以少阳病为标,三阴病又以太阴病为统。本研究观察从三阴病入手以温脏扶正祛邪法组方治疗2型糖尿病的临床疗效、对中医症候的改善作用、对胰岛素抵抗的改善作用、对糖脂代谢紊乱的纠正作用及对患者T淋巴细胞免疫功能的调节作用,并初步探讨其作用机理。
研究方法:
1.文献研究将目前中医药对2型糖尿病的研究现状进行综述,从病名、病因、病机、辨证分型、治疗等角度进行论述,提出了目前中医学认识2型糖尿病仍以阴虚燥热、气阴两虚论为主,治疗上多从清热养阴、益气养阴、健脾活血等为主,从《伤寒论》六经辨证及阳气亏虚角度论治者鲜见报道。
2.临床研究将2007年3月至2009年4月广州中医药大学第一附属医院内分泌专科门诊符合西医2型糖尿病诊断标准且中医辨证符合三阴病虚寒证患者73例分为治疗组38例和对照组35例,两组均采取相同的基础治疗,包括糖尿病教育、糖尿病饮食、适度运动等。对照组在基础治疗的基础上加西药盐酸二甲双胍片(0.50g,po,bid,饭后)及达美康(格列齐特片,80mg,po,bid,饭前)治疗,治疗组在对照组的基础上加用温脏扶正祛邪中药复方,水煎服,每日1剂,以1个月为一个疗程。观察治疗前后2型糖尿病临床疗效、中医症候疗效、中医症候积分变化,检测空腹血糖、餐后2小时血糖、空腹胰岛素、TC、TG、HDL-C、LDL-C、CD4+、CD8+、CD4+/CD8+,计算胰岛素敏感指数、胰岛素抵抗指数等并进行比较。
研究结果:
1.两组在性别、年龄、病程、中医症候积分、FBG、P_2Hbg、血脂四项、T淋巴细胞免疫功能等方面比较无明显差异(P＞0.05),具有可比性。
2.临床观察结果显示治疗组总有效率为84.3%,明显优于对照组的65.7%(P＜0.05),表明合用温脏扶正祛邪中药复方可以增强西药对T2DM的临床疗效;治疗组中医症候总有效率100.0%,明显优于对照组74.3%,说明中药在改善症状方面优于单纯西药;两组均能明显减轻患者中医症状积分(P＜0.05),差值比较治疗组优于对照组(P＜0.05),说明合用温脏扶正祛邪中药复方后可更明显改善患者症状,提高生活质量;两组均能明显降低患者的FBG和P_2hBG(P＜0.01),但治疗后两组组间比较无显着差异(P＞0.05),表明温脏扶正祛邪中药复方并非通过提高降糖效果来实现改善中医症状的作用;两组均能使空腹胰岛素、胰岛素抵抗指数明显降低,胰岛素敏感指数明显升高,与治疗前比较,有显着性差异(P＜0.05或P＜0.01),两组组间比较虽然无明显差异(P＞0.05),治疗组改善胰岛素抵抗指数及胰岛素敏感指数的作用要优于对照组,说明中药可能具有一定的改善胰岛素抵抗作用;两组治疗后TC、TG、及LDL-C均显着下降,HDL-C升高,与治疗前比较,差异有显着性意义(P＜0.05),治疗后两组比较,治疗组TC、TG及LDL-C的改善均优于对照组(P＜0.05),HDL-C较对照组亦有升高,但无统计学意义(P＞0.05),表明中药具有一定的调节血脂紊乱作用;两组治疗后CD4+、CD8+、及CD4+/CD8+均升高,其中对照组与治疗前比较,无显着性差异(P＞0.05),治疗组与治疗前比较有显着性意义(P＜0.05),表明温脏扶正祛邪中药复方对机体的T淋巴细胞免疫功能有一定的调节作用。
3.患者在服用温脏扶正祛邪中药复方过程中未出现任何毒副作用。
结论:
1.阳虚可以致消,正虚也可以致消;三阴病阳(气)亏虚伴少阳枢机不利是2型糖尿病的发病基础,在此基础上产生的寒湿痰瘀等是其重要的病理因素。针对2型糖尿病三阴阳(气)亏虚,枢机不利,邪毒内阻的特点,以温脏扶正祛邪法温三阴之脏、扶助正气、畅少阳枢机,以祛邪外出为T2DM的基本治法。
2.温脏扶正祛邪法中药复方可辅助西药提高三阴病虚寒证2型糖尿病临床疗效,减轻其中医临床症状,协助降低血糖,改善胰岛素抵抗并纠正脂代谢紊乱。
3.T2DM患者存在明显的T淋巴细胞功能降低,T淋巴细胞免疫功能与机体正气强弱关系密切,温脏扶正祛邪法中药复方能提高T2DM患者血清CD4+、CD8+及CD4+/CD8+的表达,改善2型糖尿病患者机体T淋巴细胞免疫功能,增强机体免疫力,其治疗2型糖尿病的机理并不是通过单纯降低血糖,而是通过神经-内分泌-免疫调节网络对机体进行整体调节,从而达到邪去正安的目的。
Background:
In recent years,Chinese medicine has gradually reflected a unique advantage in the treatment of type 2 diabetes mellitus(T2DM) and its complications.The role of multi-targets owned by TCM can regulate the body immune function so as to achieve the goal of 'reinforce the healthy qi to eliminate the pathogenic factors,eliminate the pathogenic factors without the healthy qi damage'.With the improvement of living standards and lifestyle changes,the incidence rate of Type 2 diabetes is getting higher and higher. It has become the third disease which result in death following after the tumor and cardiovascular diseases.For the treatment of this disease,most Chinese medicine doctors use the combination method of syndrome differentiation and disease differentiation.The common therapeutic methods include inriching yin and clearing heat,tonifying qi and inriching yin,clearing heat and engendering fluid,fortifying the spleen and resolving dampness,activating blood and resolving stasis,etc.The mechanisms are related to improving insulin resistance,adjusting the disorders of blood glucose and lipid, reducing inflammation etc.The research mentioned above deepened our knowledge of TCM treatment on T2DM.Nevertheless,there are still a lot of problems that need to be settled urgently in this field.Many factors such as constitution, environment and living habit are related to T2DM occurrence.Different treatments work at different stages of this disease.How to embody the 'syndorme differentiation' of the treatment demands further studied.
Objective:
The characteristic of healthy qi and yang qi deficiency is found in clinical on T2DM patients.From the six-meridian syndrome differentiation point of view T2DM occurs based on san-yin disease which complicated by lesser yang disease and controlled by greater disease.Based on the treatment of 'warming viscera,reinforce healthy qi and eliminate the pathogenic factors' a decoction named WenZangFuZhengquxie(WZFZ) was produced.This research is to observe the effect of WZFZ in the T2DM clinical,the improving symptoms of TCM,the improving insulin resistance,the adjusting blood blucose and lipid,the regulation of T lymphocytes immune function and primarily probe its mechanism.
Methods:
1.The present status of TCM study on T2DM is reviewed in literature research.At present,yin deficiency with internal heat and deficiency of qi and yin are the most two common mechanisms of T2DM in TCM point.Under these theories influence clinical doctors get used to the treatment methods like inriching yin and clearing heat,tonifying qi and inriching yin,fortifying the spleen and activiting blood,etc.But it is rarely in the study based on Treatise on Cold Damage Diseases and six-meridian syndrome differentiation.
2.73 T2DM patients who were diagnosed with deficiency cold syndrome blongs to san-yin disease were randomly divided in to two groups:treating group(n=38) and control group(n=35).All those patients were selected from the endocrinology clinic of the First affiliated hospital of Guangzhou university of Chinese Medicine during March 2007 to March 2009.2 groups were giver the same basal treatment including education course for diabetes,diabetic diet and moderate exercise.Patients in the control group attended to metformin hydrochloride(0.50g,po,bid,after meals) and gliclazide(80mg,po,bid, before meals).And to those in the treating group,WZFZ therapy was given additionally,one dose taken in twice a day.After 1 month' s treatment,the curative effect and Chinese medical syndromes were observed.Moreover,fasting blood glucose(FBG),post-prandial 2-hour blood glucose(P_2hBG),blood lipid, fasting insulin(FINS),insulin resistance index(IRI),insulin sensitivity index(ISI),CD4+,CD8+ and CD4+/CD8+ were measured and compared before and after treatment.
Results:
1.The difference among sex,age,TCM syndromes,FBG,P_2Hbg,blood lipid and T lymphocytes immune function were not signification between treating group and control group(P＞0.05).
2.Based on controlling the blood glucose availability,the total ratio of effective of treating group was 84.3%,control group was 65.7%.Compared with two groups,treating group was obviously excel to control group(P＜0.05).In the total effective ratio of TCM syndrome,the treating group achieved 100.0%significantly higher than the control group 74.3%(P＜0.05). Both groups had a obviously decrease in the syndrome scores(P＜0.05),while in the comparison of difference treating group was superiorer to control group (P＜0.05).FBG and P_2hBG lowered in both groups(P＜0.01),but no difference was found between the treating group and control group(P＞0.05).Both groups can decrease the FINS and IRI as well as increase the ISI(P＜0.05).Also, no difference was found between groups(P＞0.05).Both groups worked good in blood lipid regulation with a significant difference compared with before treatment(P＜0.05).Compared with two groups,treating group was superior to control group in decreasing TC,TG,and LDL-C(P＜0.05),but not significant in increasing HDL-C(P＞0.05).In the aspect of adjusting T lymphocytes immune function,compared with their levels before treatment separately,treating group made a better effect in increasing the levels of CD4+,CD8+ and CD4+/CD8+ (P＜0.05),however,the control group not(P＞0.05).
3.There are no toxicity and side-effect in tow groups.
Conclusions:
1.Yang qi of human body is deficient easy,and the deficiency of yang qi can also incur to diabetes.The same situation occurs when the healthy qi is deficient.The yang qi deficiency of san-yin disease complicated by the lesser yang disease is the main mechanism of T2DM.All the pathogenic factors include cold,dampness,phlegm and static blood are produced on this basis. According to this characteristic,a treatment method named 'warming viscera, reinforce healthy qi and eliminate the pathogenic factors' is established. And this method is used to warm the viscera of san-yin,reinforce the healthy qi,harmonize lesser yang and eliminate the pathogenic factors.
2.The WZFZ can increase the clinical efficacy of T2DM,decrease the TCM syndromes,lower FBG and P_2hBG,improve insulin resistance and injust the disorders of blood lipid.
3.Diabetic patients have a significant lower T-lymphocyte function which closely related with the healthy qi of body than normal person.WZFZ can increase the levels of CD4+,CD8+ and CD4+/CD8+ to improve the T lymphocyte function of diabetic patients and enhance the immunological function of body. The therapeutic mechanism for T2DM is not depend on the controlling blood glucose availability,but is probably pathway of relating to regulate the immunological function.It can regulate organism all round through neuro-endocrinc-immunomodulation network of the whole body.
近年来,中医药在治疗2型糖尿病及其并发症方面逐步体现出独特的优势,特别是中药复方的多靶点作用,整体调节机体免疫,达到“扶正以祛邪,祛邪不伤正”的目的。随着人们生活水平的提高及生活方式的改变,2型糖尿病的发病率越来越高,现已成为继肿瘤及心血管疾病之后第三位导致人类死亡的疾病。中医药对于本病的临床治疗现多采用辨病与辨证相结合的方法,多以养阴清热、益气养阴、清热生津、健脾化湿及活血化瘀等为主,其作用机理与改善胰岛素抵抗、调节脂糖代谢紊乱及减少炎症反应等有关。上述研究加深了对运用中医药治疗2型糖尿病的认识,但还存在不少亟待解决的问题。本病的发生与体质、环境、生活习惯等多种因素相关,不同治法在疾病的不同阶段发挥作用,如何在治法研究中体现“辨证”的思路,有待进一步探讨。
研究目的:
临床中发现2型糖尿病患者存在明显的正气不足、阳气虚弱的特点,从六经辨证的观点来看,以三阴病本,兼夹以少阳病为标,三阴病又以太阴病为统。本研究观察从三阴病入手以温脏扶正祛邪法组方治疗2型糖尿病的临床疗效、对中医症候的改善作用、对胰岛素抵抗的改善作用、对糖脂代谢紊乱的纠正作用及对患者T淋巴细胞免疫功能的调节作用,并初步探讨其作用机理。
研究方法:
1.文献研究将目前中医药对2型糖尿病的研究现状进行综述,从病名、病因、病机、辨证分型、治疗等角度进行论述,提出了目前中医学认识2型糖尿病仍以阴虚燥热、气阴两虚论为主,治疗上多从清热养阴、益气养阴、健脾活血等为主,从《伤寒论》六经辨证及阳气亏虚角度论治者鲜见报道。
2.临床研究将2007年3月至2009年4月广州中医药大学第一附属医院内分泌专科门诊符合西医2型糖尿病诊断标准且中医辨证符合三阴病虚寒证患者73例分为治疗组38例和对照组35例,两组均采取相同的基础治疗,包括糖尿病教育、糖尿病饮食、适度运动等。对照组在基础治疗的基础上加西药盐酸二甲双胍片(0.50g,po,bid,饭后)及达美康(格列齐特片,80mg,po,bid,饭前)治疗,治疗组在对照组的基础上加用温脏扶正祛邪中药复方,水煎服,每日1剂,以1个月为一个疗程。观察治疗前后2型糖尿病临床疗效、中医症候疗效、中医症候积分变化,检测空腹血糖、餐后2小时血糖、空腹胰岛素、TC、TG、HDL-C、LDL-C、CD4+、CD8+、CD4+/CD8+,计算胰岛素敏感指数、胰岛素抵抗指数等并进行比较。
研究结果:
1.两组在性别、年龄、病程、中医症候积分、FBG、P_2Hbg、血脂四项、T淋巴细胞免疫功能等方面比较无明显差异(P＞0.05),具有可比性。
2.临床观察结果显示治疗组总有效率为84.3%,明显优于对照组的65.7%(P＜0.05),表明合用温脏扶正祛邪中药复方可以增强西药对T2DM的临床疗效;治疗组中医症候总有效率100.0%,明显优于对照组74.3%,说明中药在改善症状方面优于单纯西药;两组均能明显减轻患者中医症状积分(P＜0.05),差值比较治疗组优于对照组(P＜0.05),说明合用温脏扶正祛邪中药复方后可更明显改善患者症状,提高生活质量;两组均能明显降低患者的FBG和P_2hBG(P＜0.01),但治疗后两组组间比较无显着差异(P＞0.05),表明温脏扶正祛邪中药复方并非通过提高降糖效果来实现改善中医症状的作用;两组均能使空腹胰岛素、胰岛素抵抗指数明显降低,胰岛素敏感指数明显升高,与治疗前比较,有显着性差异(P＜0.05或P＜0.01),两组组间比较虽然无明显差异(P＞0.05),治疗组改善胰岛素抵抗指数及胰岛素敏感指数的作用要优于对照组,说明中药可能具有一定的改善胰岛素抵抗作用;两组治疗后TC、TG、及LDL-C均显着下降,HDL-C升高,与治疗前比较,差异有显着性意义(P＜0.05),治疗后两组比较,治疗组TC、TG及LDL-C的改善均优于对照组(P＜0.05),HDL-C较对照组亦有升高,但无统计学意义(P＞0.05),表明中药具有一定的调节血脂紊乱作用;两组治疗后CD4+、CD8+、及CD4+/CD8+均升高,其中对照组与治疗前比较,无显着性差异(P＞0.05),治疗组与治疗前比较有显着性意义(P＜0.05),表明温脏扶正祛邪中药复方对机体的T淋巴细胞免疫功能有一定的调节作用。
3.患者在服用温脏扶正祛邪中药复方过程中未出现任何毒副作用。
结论:
1.阳虚可以致消,正虚也可以致消;三阴病阳(气)亏虚伴少阳枢机不利是2型糖尿病的发病基础,在此基础上产生的寒湿痰瘀等是其重要的病理因素。针对2型糖尿病三阴阳(气)亏虚,枢机不利,邪毒内阻的特点,以温脏扶正祛邪法温三阴之脏、扶助正气、畅少阳枢机,以祛邪外出为T2DM的基本治法。
2.温脏扶正祛邪法中药复方可辅助西药提高三阴病虚寒证2型糖尿病临床疗效,减轻其中医临床症状,协助降低血糖,改善胰岛素抵抗并纠正脂代谢紊乱。
3.T2DM患者存在明显的T淋巴细胞功能降低,T淋巴细胞免疫功能与机体正气强弱关系密切,温脏扶正祛邪法中药复方能提高T2DM患者血清CD4+、CD8+及CD4+/CD8+的表达,改善2型糖尿病患者机体T淋巴细胞免疫功能,增强机体免疫力,其治疗2型糖尿病的机理并不是通过单纯降低血糖,而是通过神经-内分泌-免疫调节网络对机体进行整体调节,从而达到邪去正安的目的。
Background:
In recent years,Chinese medicine has gradually reflected a unique advantage in the treatment of type 2 diabetes mellitus(T2DM) and its complications.The role of multi-targets owned by TCM can regulate the body immune function so as to achieve the goal of 'reinforce the healthy qi to eliminate the pathogenic factors,eliminate the pathogenic factors without the healthy qi damage'.With the improvement of living standards and lifestyle changes,the incidence rate of Type 2 diabetes is getting higher and higher. It has become the third disease which result in death following after the tumor and cardiovascular diseases.For the treatment of this disease,most Chinese medicine doctors use the combination method of syndrome differentiation and disease differentiation.The common therapeutic methods include inriching yin and clearing heat,tonifying qi and inriching yin,clearing heat and engendering fluid,fortifying the spleen and resolving dampness,activating blood and resolving stasis,etc.The mechanisms are related to improving insulin resistance,adjusting the disorders of blood glucose and lipid, reducing inflammation etc.The research mentioned above deepened our knowledge of TCM treatment on T2DM.Nevertheless,there are still a lot of problems that need to be settled urgently in this field.Many factors such as constitution, environment and living habit are related to T2DM occurrence.Different treatments work at different stages of this disease.How to embody the 'syndorme differentiation' of the treatment demands further studied.
Objective:
The characteristic of healthy qi and yang qi deficiency is found in clinical on T2DM patients.From the six-meridian syndrome differentiation point of view T2DM occurs based on san-yin disease which complicated by lesser yang disease and controlled by greater disease.Based on the treatment of 'warming viscera,reinforce healthy qi and eliminate the pathogenic factors' a decoction named WenZangFuZhengquxie(WZFZ) was produced.This research is to observe the effect of WZFZ in the T2DM clinical,the improving symptoms of TCM,the improving insulin resistance,the adjusting blood blucose and lipid,the regulation of T lymphocytes immune function and primarily probe its mechanism.
Methods:
1.The present status of TCM study on T2DM is reviewed in literature research.At present,yin deficiency with internal heat and deficiency of qi and yin are the most two common mechanisms of T2DM in TCM point.Under these theories influence clinical doctors get used to the treatment methods like inriching yin and clearing heat,tonifying qi and inriching yin,fortifying the spleen and activiting blood,etc.But it is rarely in the study based on Treatise on Cold Damage Diseases and six-meridian syndrome differentiation.
2.73 T2DM patients who were diagnosed with deficiency cold syndrome blongs to san-yin disease were randomly divided in to two groups:treating group(n=38) and control group(n=35).All those patients were selected from the endocrinology clinic of the First affiliated hospital of Guangzhou university of Chinese Medicine during March 2007 to March 2009.2 groups were giver the same basal treatment including education course for diabetes,diabetic diet and moderate exercise.Patients in the control group attended to metformin hydrochloride(0.50g,po,bid,after meals) and gliclazide(80mg,po,bid, before meals).And to those in the treating group,WZFZ therapy was given additionally,one dose taken in twice a day.After 1 month' s treatment,the curative effect and Chinese medical syndromes were observed.Moreover,fasting blood glucose(FBG),post-prandial 2-hour blood glucose(P_2hBG),blood lipid, fasting insulin(FINS),insulin resistance index(IRI),insulin sensitivity index(ISI),CD4+,CD8+ and CD4+/CD8+ were measured and compared before and after treatment.
Results:
1.The difference among sex,age,TCM syndromes,FBG,P_2Hbg,blood lipid and T lymphocytes immune function were not signification between treating group and control group(P＞0.05).
2.Based on controlling the blood glucose availability,the total ratio of effective of treating group was 84.3%,control group was 65.7%.Compared with two groups,treating group was obviously excel to control group(P＜0.05).In the total effective ratio of TCM syndrome,the treating group achieved 100.0%significantly higher than the control group 74.3%(P＜0.05). Both groups had a obviously decrease in the syndrome scores(P＜0.05),while in the comparison of difference treating group was superiorer to control group (P＜0.05).FBG and P_2hBG lowered in both groups(P＜0.01),but no difference was found between the treating group and control group(P＞0.05).Both groups can decrease the FINS and IRI as well as increase the ISI(P＜0.05).Also, no difference was found between groups(P＞0.05).Both groups worked good in blood lipid regulation with a significant difference compared with before treatment(P＜0.05).Compared with two groups,treating group was superior to control group in decreasing TC,TG,and LDL-C(P＜0.05),but not significant in increasing HDL-C(P＞0.05).In the aspect of adjusting T lymphocytes immune function,compared with their levels before treatment separately,treating group made a better effect in increasing the levels of CD4+,CD8+ and CD4+/CD8+ (P＜0.05),however,the control group not(P＞0.05).
3.There are no toxicity and side-effect in tow groups.
Conclusions:
1.Yang qi of human body is deficient easy,and the deficiency of yang qi can also incur to diabetes.The same situation occurs when the healthy qi is deficient.The yang qi deficiency of san-yin disease complicated by the lesser yang disease is the main mechanism of T2DM.All the pathogenic factors include cold,dampness,phlegm and static blood are produced on this basis. According to this characteristic,a treatment method named 'warming viscera, reinforce healthy qi and eliminate the pathogenic factors' is established. And this method is used to warm the viscera of san-yin,reinforce the healthy qi,harmonize lesser yang and eliminate the pathogenic factors.
2.The WZFZ can increase the clinical efficacy of T2DM,decrease the TCM syndromes,lower FBG and P_2hBG,improve insulin resistance and injust the disorders of blood lipid.
3.Diabetic patients have a significant lower T-lymphocyte function which closely related with the healthy qi of body than normal person.WZFZ can increase the levels of CD4+,CD8+ and CD4+/CD8+ to improve the T lymphocyte function of diabetic patients and enhance the immunological function of body. The therapeutic mechanism for T2DM is not depend on the controlling blood glucose availability,but is probably pathway of relating to regulate the immunological function.It can regulate organism all round through neuro-endocrinc-immunomodulation network of the whole body.
引文
[1]Olefsky J M.Diabetes mellitus.In:Wyngarrden JB,Smith,TC,eds.Cecil textbook of medicine.19~(th) edition.W.B.Saunders Company,Philadelphia,1992:1291.
[2]高彦彬.古今糖尿病医论医案选[M].北京:人民军医出版社,2005:1.
[3]邢玫.从脾论治糖尿病[J].中医药研究,1998,13(5):18.
[4]赵进喜.糖尿病及其并发症中医药防治现状与前景展望[J].中华中医药杂志,2003,2:1-5.
[5]李育才,初淑华,王耀华,等.施今墨先生治疗糖尿病的经验[J].辽宁中医杂志,1986;10(4):5-7
[6]魏庆兴.赵锡武诊治消渴的经验[J].中医杂志,1992;33(1):14-15
[7]章向明.章真如治疗糖尿病的经验[J].江西中医药,1994;25(5):5-6
[8]张永忠,匡黎明,周杰等.清热解毒法治疗2型糖尿病30例[J].光明中医,2008,23(5):632-634.
[9]李冀,王春丽.消渴从心辨证论治[J].中医药学报,2000,1:1-5.
[10]范金茹.王行宽教授从心肝论治消渴病的经验.湖南中医学院学报,1998;18(4):24
[11]于志强,高风琴.酸泻肝木法治疗消渴[J].四川中医,1994;12(2):24-25
[12]邹如政.糖尿病从肝论治.中国医药学报[J],1998;13(1):19-23
[13]王智明,魏子孝.从肝论治消渴(糖尿病)的理论探讨[J].中国中医基础医学杂志,1999;5(4):34-35
[14]邱志济,朱建平,马璇卿.朱良春治疗糖尿病用药经验和特色选析[J].辽宁中医杂志,2003;30(3):163-164
[15]史文丽,赵军.李炳文从肝论治糖尿病经验[J].北京中医药大学学报,2004;11 (3):28
[16]王晖,王健康.糖尿病辨证论治新法[J].中医杂志,1999,40(8):507.
[17]程汗桥.肝气郁结与消渴病关系的理论研究[J].江苏中医,1997,18(9):35.
[18]王智明.从肝论治消渴(糖尿病)的理论探讨[J].中国中医基础医学杂志,1999,5(4):34.
[19]魏军平,周丽波,刘芳等.2型糖尿病患者体型与证候特点研究[J].中华中医药学刊.2007,25(12):2653-2655.
[20]谢杜红,仝小林,徐远.糖尿病从肝胃辨治论[J].中国中医药信息杂志,2003;10(2):7-8
[21]仝小林.消渴六论.中医杂志[J],2001;42(4):252
[22]林雪.仝小林诊治糖尿病经验[J].中国社区医师,2003;19:36-37
[23]李成霞.调气降火法治疗难治性高血糖[J].新疆中医药,2004,22(5):22-23
[24]熊维政,陈元宏,夏辉.参芪降糖胶囊治疗轻中度2型糖尿病的探讨[J].首都医药.2006,6:30-31.
[25]熊曼琪.脾虚是消渴病的重要病机[J].广州中医学院学报,1991;8(1):1-4
[26]吴以岭.消渴病从脾论治探讨[J].中医杂志,2002;43(6):410-411
[27]顾维超,顾润环.试论糖尿病从脾施治[J].南京中医药大学学报,1997;13(16):361-362
[28]高彦彬.古今糖尿病医论医案选[M].北京:人民军医出版社,2005(第1版),120
[29]王保瑞,王海鹏.陆文正老中医治疗糖尿病的经验[J].陕西中医,1992;13(6):262
[30]魏庆兴.赵锡武诊治消渴的经验[J].中医杂志,1992;33(1):14-15
[31]史宇广,单书健.当代名医临证精华·消渴专辑[M].北京:中医古籍出版社,1992,127-129
[32]温子龙.邓铁涛老中医治疗中老年消渴病的经验[J].中医研究,2001;14(6):42-43
[33]李琪,高阳.刘启庭治疗老年性糖尿病经验[J].黑龙江中医药,1997;(3):3-5
[34]王旭.陈金锭教授治疗内分泌病经验撷要[J].南京中医药大学学报,2000;16(3):176-178
[35]鲍陶陶.2型糖尿病胰岛β细胞功能受损的中西医病机探讨[J].安徽中医学院学报.2006,25(3):63-64.
[36]匡奕璜.糖尿病并发症的中医药治疗[J].江西中医药,2000,5:56.
[37]陈亚民,何建华.葛健文治疗糖尿病经验[J].甘肃中医,2004;17(2):15-16
[38]周则卫.2型糖尿病发生胰岛素抵抗机理的中医探讨[J].天津中医,2002,19(4):38-39
[39]陆付耳,王智明,郭爱群.糖尿病从”毒”论治探讨[J].中国中医基础医学杂志,2002,3(5):15-17
[40]邓德强.谷培恒教授培土活血解毒治疗糖尿病经验[J].新疆中医药,2001;19(4):56-58
[41]王如沾,曲卫毅.论毒与糖尿病[J].山东中医杂志,1999,18(8):339-341
[42]杨辰华.2型糖尿病胰岛素抵抗从痰湿论治的思路.中医研究.2006,19(6):2-4.
[43]曹忠贞.论消渴与痰[J].中医药研究,1997,13(2):8-9
[44]孙学东,姚华.活血化瘀法治疗2型糖尿病临床观察[J].中国医院用药评价与分析,2008,8(5):386-387.
[45]蒲翔,冯泳.理气活血法治疗2型糖尿病的探析[J].时珍国医国药,2007,18(10):2560-2561.
[46]梁光宇.冯明清教授治疗糖尿病学术思想简介[J].河南中医2000,20(1):15.
[47]杨丽萍,王伟,王庆国.肾虚糖尿病家系中的血瘀证研究[J].中华中医药杂志,2006,9(8):47
[48]张清梅,陈泽奇.1490例2型糖尿病临床辨证分型调查分析[J].湖南中医学院学报,2004,24(5):33-35.
[49]祝堪予,郭赛珊,梁晓春.对糖尿病中医辨证标准及施治方药的探讨[J].上海中医药杂志,1982,(6):5.
[50]林兰.糖尿病的中西医结合论治[M].北京:北京科学技术出版社。1992.143-151.
[51]张延群.消渴病定义及辨证分型标准化探讨[J].山东中医学院学报,1995,19(1):25.
[52]程汉桥,高蕊.浅谈糖尿病从脾辨治[J].安徽中医临床杂志,1997,9(6):340.
[53]吕仁和.糖尿病及其井发症中西医诊治学[M].北京:人民卫生出版社。1997.128-130,238-243.
[54]王立人,糖尿病中西医结合诊断分期法的意义与应用[J].辽宁实用糖尿病杂志.2003,11(2):17.
[55]李普宏.203例2型糖尿病的中医辨证分型研究[J].河南中医,2004,3(24):3.
[56]刘志群.2型糖尿病中医辨证施治体会[J].四川中医,2006,24(11):20
[57]张庆兰.糖尿病的中医辨证分型[J].甘肃中医,2006,19(7):6.
[58]陆源源,陆岚.79例2型糖尿病病例中医证候分布规律探析[J].浙江中医杂志,2006,41(11):630-631.
[59]林兰编着.中西医结合糖尿病学[M].北京:中国医药科技出版社,第1版,1995
[60]李志文,周洪,柴国钊,等.任继学教授辨治糖尿病经验[J].河北中医,1991,13(6):18
[61]郭庆贺,郭连川,杨凤珍,等.系列中药治疗型糖尿病3000例[J].辽宁中医杂志,1992,19(9):36-37
[62]周光才.辨证治疗2型糖尿病70例总结[J].湖南中医杂志.2006,22(2):25-26.
[63]仝小林,张志远.中医对代谢综合征的认识和治疗[J].中医杂志,2002,43(9):708-709.
[64]杨辰华.2型糖尿病胰岛素抵抗从痰湿论治的思路[J].中医研究.2006,19(6):2-4.
[65]蔺志娟,王锁欣.调血平消法治疗2型糖尿病初探[J].2007,14(10):84.
[66]吕仁和,赵进喜,王世东.糖尿病及其并发症的临床研究[J].新中医,2001,33(3):325
[67]焦晓明.从气血津液辨证论治糖尿病86例疗效观察[J].新中医,2002,34(10):33-34.
[68]罗文聪.养阴活血化瘀法治疗Ⅱ型糖尿病68例体会[J].云南中医中药杂志,2000,21(4):17-18
[69]玉山江.林兰教授诊治糖尿病经验[J].中医研究,2002,15(2):43-44
[70]张炜,叶红英.益气养阴方治疗Ⅱ型糖尿病的疗效观察[J].时珍国医国药2002,13(18):479-480
[71]梁幼雅,陈蔚文,李建平.从调理脾胃升降之枢论治糖尿病[J].新中医,2002,3(4):5-6
[72]刘桂滨.老年糖尿病从脾论治四法[J].四川中医.2000,18(10):7-8
[73]朱汀,孙寒静.冯明清教授从脾论治糖尿病经验[J].四川中医,2002,20(4):3
[74]曾永红,王育珊,黄晓红,等.中西医结合防治IGT及轻型糖尿病疗效观察[J].中西医结合脾胃杂志,2000;8(4):196-198
[75]何颖.中药改善中老年IGT并脂代谢异常[J].长治医学院学报,2000;14(2):138-139
[76]范冠杰,罗广波,覃美琳,等.降糖补肾方对糖耐量低减患者干预治疗的影响[J].中国中西医结合杂志,2004;24(4):317-320
[77]杨殿荣,邢陆.壮肾三消片干预IGT的临床研究[J].中华医学写作杂志,2003;10(4):351-353
[78]郭英,张爱华,曹卫华.首杞胶囊对糖调节受损患者的临床干预[J].实用糖尿病杂志,2007;3(4):28-29
[79]安淑华.补肾祛痰法治疗糖耐量低减的临床观察[J].四川中医,2007;25(5):44-45
[80]翟联霞,柯进.中药治疗糖耐量异常50例[J].江苏中医药,2003;24(7):31
[81]薄庆,仲崇涛.中药治疗糖耐量异常60例临床观察[J].中华实用中西医杂志,2002;(2):222-223
[82]郝爱真,呼健,刘哲峰.消渴化瘀片干预治疗糖耐量减低的临床观察[J].解放军医学杂志,2004;29(11):993-994
[83]辛雪香.健脾补肾丸干预治疗糖耐量减低68例临床观察[J].河北中医,2007;29(4):302-303
[84]王芬,何华亮.调肝法论治糖尿病初探[J].陕西中医,2004,2(10):907.
[85]鞠祥宗.韦淑萍.从肝论治糖尿病40例[J].陕西中医,2003,24(3):201
[86]周岩.疏肝解郁法治疗糖尿病24例[J].国医论坛,2004,19(1):28
[87]张欣,郭叶楠.活血祛痰通腑法治疗糖耐量减低的临床观察[J].辽宁中医杂志,2003:30(6):472
[88]袁宪章.对糖尿病胰岛素抵抗从痰湿论治的认识[J].内蒙古中医药,2002(5):2
[89]谢谋华,路翠棉.化浊抑糖丸对2型糖尿病前期干预的临床观察[J].河南中医,2007:27(8):40-41
[90]范冠杰.专科专病名医临证经验丛书[M].糖尿病.北京:人民卫生出版社,2004:2.
[91]熊曼琪,朱章志.泻热逐瘀法治疗2型糖尿病的依据与作用探讨们[J].江西中医,1996,27(2):20.
[92]刘喜明.试论消渴病临床面貌与概念的变化[J].世界中西医结合杂志,2007,2(4):187-189.
[93]玉山江.糖尿病从热毒论治探要[J].新疆中医药,2000,18(4):7-8
[94]余胜利.陈氏降糖方治疗2型糖尿病临床观察[J].中国中医药科技.2007,16(5):374-375.
[95]鞠娟.“降糖饮”袋泡剂治疗2型糖尿病60例[J].现代中西医结合杂志.2007,16(34):5146-5147.
[96]蔡寒青,葛焕琦,张秀娟,等.天芪降糖胶囊治疗2型糖尿病60例临床观察[J].吉林大学学报.2003,29(5):669.
[97]刘瑞霞,吴红,徐东娟,等.左归丸化裁治疗糖尿病黎明现象30例[J].中国中医药信息杂志,2005,8(12).
[98]常风云,蔡冀民,郭喜军,等.消糖康治疗2型糖尿病胰岛素抵抗的临床研究[J].中华实用中西医杂志,2004,4(17):79-80.
[99]朴信映,仝小林.开郁清胃颗粒对2型糖尿病胰岛素敏感性的研究[J].中国中医药信息杂志,2003,10(10):11-13.
[100]石鹤峰.消渴Ⅱ号治疗2型糖尿病86例[J].光明中医,2002,17(99):46-47
[101]陈星.俞消丸治疗2型糖尿病60例[J].陕西中医,2003,24(10):908.
[102]陆智慧,王勇,毛秉环.中西医结合治疗胰岛素抵抗综合征34例临床观察[J].湖北中医杂志,2000,22(2):18-19.
[103]高书荣,卜建宏,朱良争.芪连汤与降糖药联合干预2型糖尿病胰岛素抵抗及对相关炎症细胞因子的影响[J].中国中西医结合杂志,2004,24(7):593-595.
[104]阎满堂.中西医结合治疗2型糖尿病45例临床观察[J].中医药导报,2005,11(7):24-25.
[105]李俊成,段宏宪,杨志霞.疏糖丹治疗2型糖尿病的临床观察[J].中医药学刊,2004,22(6):1001-1002.
[106]曹瑛.白虎人参汤加减与西药联合应用治疗2型糖尿病54例临床观察[J].中医药导报.2007,13(11):18-20.
[107]刘志群,许轶兰.参芪地黄汤治疗老年2型糖尿病62例[J].陕西中医.2006,25(9):929-930.
[108]郑仲华,曾庆明,李玲.参芪健脾汤联合二甲双胍治疗2型糖尿病胰岛素抵抗[J].中原医刊.2007,34(20):37-38.
[109]杨喜忠,孙静,康小刚,等.中医辨证分型治疗2型糖尿病疗效观察[J].现代护理,2007,2(13):487.
[110]王明山,马伟杰,杜翠红.地冬复胰胶囊配合西药治疗2型糖尿病临床观察[J].河北中医,2006,28(2):126-127.
[111]徐厚谦,中医药治疗糖尿病临床研究分析[J].中医研究,1997,13(2):29
[112]丁学屏.历代消渴名方治疗糖尿病的疗效述评[J].见林兰.中西医结合糖尿病研究进展[M].北京:海洋出版社,2000.79
[113]徐洁,钟丽娟.肉桂对2型糖尿病大鼠肝糖原、肌糖原的影响[J].中国中医药科技,2007,14(3):171-172.
[114]陈其明,谢明智.黄连及小檗碱降血糖作用的研究[J].药学学报,1986,21(6):401.
[115]胡发光,杜丙信,冯光.实用中西医结合杂志[J],1995,8(6):358.
[116]刘宝义,李英.黄芪对糖尿病肾脏保护作用[J].医学综述,2003,9(3):163.
[117]李先荣,董彦敏,程林忠,等.黄芪多糖冲剂治疗Ⅱ型糖尿病的临床研究[J].山西中医,1995,11(1):16.
[118]张宗明.针药结合治疗2型糖尿病的临床观察[J].湖北中医杂志,2007,3:35.
[119]李杭.耳穴贴压法辅助治疗2型糖尿病临床观察[J].实用中医内科杂志,2007,21(2):108.
[120]萧言生.糖尿病保健四大穴位[J].中华养生保健,2008,6:30-31.
[121]张世勤.推拿配合药物治疗2型糖尿病24例临床观察[J].吉林中医药,2008,28(3):177-178.
[1]李光伟,潘孝仁,Lilliojas等.检测人群胰岛素敏感性的一项新指标[J].中华内科杂志,1993:32(10):656
[2]郑莜萸主编.中药新药临床研究指导原则[M].中国中医药科技出版社,2002,233-238
[1]Pickup JC.Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes[J].Diabetes Care,2004,27(3):813-823
[2]Tanaka S,Isoda F,Ishlhara Y,et al.T lymphopaenia in relation to body mass index and TNF-alpha in human obesity:adequate weight reduction can be corrective[J].Clin Edocrinol,2001,54(3):347-354
[3]方芳,陈晓春,陈硕琪,等.老年糖尿病患者T淋巴细胞亚群的变化及临床意义[J].福建医科大学学报,2000,34(2):170-171
[4]Keane WF,Lyle PA.Recent advances in management of type 2 diabetes and nephropathy:lessons from the RENAAL study[J].Am J Kidney Dis,2003,41(3):22-25
[5]Mackay CR.T-cell memory:the connection between function,phenotype and migration pathways[J].Immunol Today,1991,12(6):189-192
[6]王妲.糖尿病与感染[J].中华内科杂志,1997,36(10):716-717
[7]Shau H,Gupta RK,Golub SH.Identification of a natural killer enhancing factor(NKEF) from human erythroid cells[J].Cell Immunol,1993,147(1):1-11
[8]盛宏光,金惠.2型糖尿病与流式细胞CD系列关系探讨[J].浙江预防医学,2001,13(7):53-54
[9]杨淑艳.2型糖尿病患者T淋巴细胞亚群测定及意义[J].白求恩军医学院学报,2007,5(4):234-235
[10]刘成玉,曲彦,谭润鸾.急性心肌梗塞病人血清sIL-2R、mIL-2R和T细胞亚群的变化[J].高血压杂志,1997,5(1):30-32
[11]沈泓,刘超,卜瑞芳等.2型糖尿病患者T细胞亚群、TNF-α及IL-10的相关性研究[J].天津医药,2007,35(11):823-825
[12]何萍,张学亮,张学光.参地糖脉宁对糖尿病大鼠免疫系统的影响[J].中国中医药信息杂志,2008,15(10):27-29
[13]李朝晖,苏琳,刘振清.参芪扶正注射液对糖尿病患者免疫功能的影响[J].中国医疗前沿,2008,3(15):22-23
[14]富宏,王学美,刘庚信.糖尿病中医辨证与T淋巴细胞亚群及NK细胞的相关性的研究[J].中华实用中西医杂志,2002,2(15):388-389
[15]刘芳,刘沈林,余江毅.维糖平对2型糖尿病免疫功能的影响[J].辽宁中医杂志,2002,29(12):756-757
[16]王健,管月帆.益寿永真液对老年2型糖尿病患者免疫功能的影响[J].浙江中医学院学报,2002,26(3):31-32
[17]齐敦禹,李兴海,王耀光等.太极拳运动对2型糖尿病患者免疫机能影响的研究[J].北京体育大学学报,2008,31(7):932-93
[18]李可.李可老中医急危重症疑难病经验专辑[M].山西.山西科学技术出版社,2002.45页.
[19]陈亦人.中医药发展新论[M].北京:中国科学技术出版社,1995.910页.
[20]刘力红.思考中医[M].第二版.广西:广西师范大学出版社,2003.458-460页.
[21]江剑.六经津液辨证论治消渴探析[J].实用中医内科杂志,2007,21(9):31-32.
[22]全世建,黎同明,刘妮.麻子仁丸治疗2型糖尿病便秘40例[J].陕西中医,2005,26(12):1357-1358.
[23]周英,蓝柳贵,封翠芸等.彭万年经方治疗糖尿病肾病经验举要[J].山东中医杂志,2006,25(11):773-774.
[24]赵进喜.《伤寒论》三阴三阳新解及其临床发挥[J].中医杂志,2007,48(3):208.赵进喜.三阴三阳辨证与糖尿病[J].中国中医药现代远程教育,2004,2(12):31
[25]魏丹蕾.试论厥阴病理论对糖尿病神经病变诊治的意义[J].广州中医药大学学报,2007,24(4):343-345.
[26]傅强.小柴胡汤加减治疗糖尿病酮症一例[J].环球中医药,2008,3:27.
[27]汪栋材,朱章志,蔡文就.熊曼琪运用经方治疗糖尿病经验[J].中国医药学报,2000,15(5):42-44.
[28]熊曼琪,林安钟,朱章志等.加味桃核承气汤对2型糖尿病大鼠胰岛素抵抗的影响[J].中国中西医结合杂志,1997,17(3):165-168.
[29]唐咸玉,周泉.糖尿病阳虚枢机不利探微[J].中医杂志,2006,47(12):886-887.
[30]李赛美.浅谈糖尿病及其并发症六经辨治思路[J].中华中医药杂志,2007,22(12):857-859.
[31]朱章志,唐咸玉.经方治疗糖尿病研究现状及其拓展运用探讨[J].华夏医药,2006,6:421-423.
[32]朱章志,任培华.扶正祛邪法方药对2型糖尿病患者胰岛素抵抗的影响[J].华夏医药,2007,1:12-13.
[33]唐咸玉,朱章志.温阳法在糖尿病治疗中的应用[J].实用中医内科杂志,2007,21(3):76-77
[34]张振忠.温阳利水法治疗消渴[J].陕西中医函授,1998,(2):13-14.
[35]唐咸玉,朱章志,陈利.温肾健脾、祛毒活血法对早期糖尿病肾病及IL-6、TNF -α的影响[J].中药新药与临床药理,2009,20(2):175-179.
[36]蔡永敏,徐学功.试论温阳法为治疗消渴病之大法[J].上海中医药杂志,2003,37(9):52-53.
[37]宁亚攻,彭仲杰.温阳活血治消渴一例报告[J].云南中医中药杂志,1996,17(3):74-74.
[38]刘立昌,桑树贤.桑景武运用真武汤治疗消渴病的经验[J].吉林中医药,1991,3:11.
[2]高彦彬.古今糖尿病医论医案选[M].北京:人民军医出版社,2005:1.
[3]邢玫.从脾论治糖尿病[J].中医药研究,1998,13(5):18.
[4]赵进喜.糖尿病及其并发症中医药防治现状与前景展望[J].中华中医药杂志,2003,2:1-5.
[5]李育才,初淑华,王耀华,等.施今墨先生治疗糖尿病的经验[J].辽宁中医杂志,1986;10(4):5-7
[6]魏庆兴.赵锡武诊治消渴的经验[J].中医杂志,1992;33(1):14-15
[7]章向明.章真如治疗糖尿病的经验[J].江西中医药,1994;25(5):5-6
[8]张永忠,匡黎明,周杰等.清热解毒法治疗2型糖尿病30例[J].光明中医,2008,23(5):632-634.
[9]李冀,王春丽.消渴从心辨证论治[J].中医药学报,2000,1:1-5.
[10]范金茹.王行宽教授从心肝论治消渴病的经验.湖南中医学院学报,1998;18(4):24
[11]于志强,高风琴.酸泻肝木法治疗消渴[J].四川中医,1994;12(2):24-25
[12]邹如政.糖尿病从肝论治.中国医药学报[J],1998;13(1):19-23
[13]王智明,魏子孝.从肝论治消渴(糖尿病)的理论探讨[J].中国中医基础医学杂志,1999;5(4):34-35
[14]邱志济,朱建平,马璇卿.朱良春治疗糖尿病用药经验和特色选析[J].辽宁中医杂志,2003;30(3):163-164
[15]史文丽,赵军.李炳文从肝论治糖尿病经验[J].北京中医药大学学报,2004;11 (3):28
[16]王晖,王健康.糖尿病辨证论治新法[J].中医杂志,1999,40(8):507.
[17]程汗桥.肝气郁结与消渴病关系的理论研究[J].江苏中医,1997,18(9):35.
[18]王智明.从肝论治消渴(糖尿病)的理论探讨[J].中国中医基础医学杂志,1999,5(4):34.
[19]魏军平,周丽波,刘芳等.2型糖尿病患者体型与证候特点研究[J].中华中医药学刊.2007,25(12):2653-2655.
[20]谢杜红,仝小林,徐远.糖尿病从肝胃辨治论[J].中国中医药信息杂志,2003;10(2):7-8
[21]仝小林.消渴六论.中医杂志[J],2001;42(4):252
[22]林雪.仝小林诊治糖尿病经验[J].中国社区医师,2003;19:36-37
[23]李成霞.调气降火法治疗难治性高血糖[J].新疆中医药,2004,22(5):22-23
[24]熊维政,陈元宏,夏辉.参芪降糖胶囊治疗轻中度2型糖尿病的探讨[J].首都医药.2006,6:30-31.
[25]熊曼琪.脾虚是消渴病的重要病机[J].广州中医学院学报,1991;8(1):1-4
[26]吴以岭.消渴病从脾论治探讨[J].中医杂志,2002;43(6):410-411
[27]顾维超,顾润环.试论糖尿病从脾施治[J].南京中医药大学学报,1997;13(16):361-362
[28]高彦彬.古今糖尿病医论医案选[M].北京:人民军医出版社,2005(第1版),120
[29]王保瑞,王海鹏.陆文正老中医治疗糖尿病的经验[J].陕西中医,1992;13(6):262
[30]魏庆兴.赵锡武诊治消渴的经验[J].中医杂志,1992;33(1):14-15
[31]史宇广,单书健.当代名医临证精华·消渴专辑[M].北京:中医古籍出版社,1992,127-129
[32]温子龙.邓铁涛老中医治疗中老年消渴病的经验[J].中医研究,2001;14(6):42-43
[33]李琪,高阳.刘启庭治疗老年性糖尿病经验[J].黑龙江中医药,1997;(3):3-5
[34]王旭.陈金锭教授治疗内分泌病经验撷要[J].南京中医药大学学报,2000;16(3):176-178
[35]鲍陶陶.2型糖尿病胰岛β细胞功能受损的中西医病机探讨[J].安徽中医学院学报.2006,25(3):63-64.
[36]匡奕璜.糖尿病并发症的中医药治疗[J].江西中医药,2000,5:56.
[37]陈亚民,何建华.葛健文治疗糖尿病经验[J].甘肃中医,2004;17(2):15-16
[38]周则卫.2型糖尿病发生胰岛素抵抗机理的中医探讨[J].天津中医,2002,19(4):38-39
[39]陆付耳,王智明,郭爱群.糖尿病从”毒”论治探讨[J].中国中医基础医学杂志,2002,3(5):15-17
[40]邓德强.谷培恒教授培土活血解毒治疗糖尿病经验[J].新疆中医药,2001;19(4):56-58
[41]王如沾,曲卫毅.论毒与糖尿病[J].山东中医杂志,1999,18(8):339-341
[42]杨辰华.2型糖尿病胰岛素抵抗从痰湿论治的思路.中医研究.2006,19(6):2-4.
[43]曹忠贞.论消渴与痰[J].中医药研究,1997,13(2):8-9
[44]孙学东,姚华.活血化瘀法治疗2型糖尿病临床观察[J].中国医院用药评价与分析,2008,8(5):386-387.
[45]蒲翔,冯泳.理气活血法治疗2型糖尿病的探析[J].时珍国医国药,2007,18(10):2560-2561.
[46]梁光宇.冯明清教授治疗糖尿病学术思想简介[J].河南中医2000,20(1):15.
[47]杨丽萍,王伟,王庆国.肾虚糖尿病家系中的血瘀证研究[J].中华中医药杂志,2006,9(8):47
[48]张清梅,陈泽奇.1490例2型糖尿病临床辨证分型调查分析[J].湖南中医学院学报,2004,24(5):33-35.
[49]祝堪予,郭赛珊,梁晓春.对糖尿病中医辨证标准及施治方药的探讨[J].上海中医药杂志,1982,(6):5.
[50]林兰.糖尿病的中西医结合论治[M].北京:北京科学技术出版社。1992.143-151.
[51]张延群.消渴病定义及辨证分型标准化探讨[J].山东中医学院学报,1995,19(1):25.
[52]程汉桥,高蕊.浅谈糖尿病从脾辨治[J].安徽中医临床杂志,1997,9(6):340.
[53]吕仁和.糖尿病及其井发症中西医诊治学[M].北京:人民卫生出版社。1997.128-130,238-243.
[54]王立人,糖尿病中西医结合诊断分期法的意义与应用[J].辽宁实用糖尿病杂志.2003,11(2):17.
[55]李普宏.203例2型糖尿病的中医辨证分型研究[J].河南中医,2004,3(24):3.
[56]刘志群.2型糖尿病中医辨证施治体会[J].四川中医,2006,24(11):20
[57]张庆兰.糖尿病的中医辨证分型[J].甘肃中医,2006,19(7):6.
[58]陆源源,陆岚.79例2型糖尿病病例中医证候分布规律探析[J].浙江中医杂志,2006,41(11):630-631.
[59]林兰编着.中西医结合糖尿病学[M].北京:中国医药科技出版社,第1版,1995
[60]李志文,周洪,柴国钊,等.任继学教授辨治糖尿病经验[J].河北中医,1991,13(6):18
[61]郭庆贺,郭连川,杨凤珍,等.系列中药治疗型糖尿病3000例[J].辽宁中医杂志,1992,19(9):36-37
[62]周光才.辨证治疗2型糖尿病70例总结[J].湖南中医杂志.2006,22(2):25-26.
[63]仝小林,张志远.中医对代谢综合征的认识和治疗[J].中医杂志,2002,43(9):708-709.
[64]杨辰华.2型糖尿病胰岛素抵抗从痰湿论治的思路[J].中医研究.2006,19(6):2-4.
[65]蔺志娟,王锁欣.调血平消法治疗2型糖尿病初探[J].2007,14(10):84.
[66]吕仁和,赵进喜,王世东.糖尿病及其并发症的临床研究[J].新中医,2001,33(3):325
[67]焦晓明.从气血津液辨证论治糖尿病86例疗效观察[J].新中医,2002,34(10):33-34.
[68]罗文聪.养阴活血化瘀法治疗Ⅱ型糖尿病68例体会[J].云南中医中药杂志,2000,21(4):17-18
[69]玉山江.林兰教授诊治糖尿病经验[J].中医研究,2002,15(2):43-44
[70]张炜,叶红英.益气养阴方治疗Ⅱ型糖尿病的疗效观察[J].时珍国医国药2002,13(18):479-480
[71]梁幼雅,陈蔚文,李建平.从调理脾胃升降之枢论治糖尿病[J].新中医,2002,3(4):5-6
[72]刘桂滨.老年糖尿病从脾论治四法[J].四川中医.2000,18(10):7-8
[73]朱汀,孙寒静.冯明清教授从脾论治糖尿病经验[J].四川中医,2002,20(4):3
[74]曾永红,王育珊,黄晓红,等.中西医结合防治IGT及轻型糖尿病疗效观察[J].中西医结合脾胃杂志,2000;8(4):196-198
[75]何颖.中药改善中老年IGT并脂代谢异常[J].长治医学院学报,2000;14(2):138-139
[76]范冠杰,罗广波,覃美琳,等.降糖补肾方对糖耐量低减患者干预治疗的影响[J].中国中西医结合杂志,2004;24(4):317-320
[77]杨殿荣,邢陆.壮肾三消片干预IGT的临床研究[J].中华医学写作杂志,2003;10(4):351-353
[78]郭英,张爱华,曹卫华.首杞胶囊对糖调节受损患者的临床干预[J].实用糖尿病杂志,2007;3(4):28-29
[79]安淑华.补肾祛痰法治疗糖耐量低减的临床观察[J].四川中医,2007;25(5):44-45
[80]翟联霞,柯进.中药治疗糖耐量异常50例[J].江苏中医药,2003;24(7):31
[81]薄庆,仲崇涛.中药治疗糖耐量异常60例临床观察[J].中华实用中西医杂志,2002;(2):222-223
[82]郝爱真,呼健,刘哲峰.消渴化瘀片干预治疗糖耐量减低的临床观察[J].解放军医学杂志,2004;29(11):993-994
[83]辛雪香.健脾补肾丸干预治疗糖耐量减低68例临床观察[J].河北中医,2007;29(4):302-303
[84]王芬,何华亮.调肝法论治糖尿病初探[J].陕西中医,2004,2(10):907.
[85]鞠祥宗.韦淑萍.从肝论治糖尿病40例[J].陕西中医,2003,24(3):201
[86]周岩.疏肝解郁法治疗糖尿病24例[J].国医论坛,2004,19(1):28
[87]张欣,郭叶楠.活血祛痰通腑法治疗糖耐量减低的临床观察[J].辽宁中医杂志,2003:30(6):472
[88]袁宪章.对糖尿病胰岛素抵抗从痰湿论治的认识[J].内蒙古中医药,2002(5):2
[89]谢谋华,路翠棉.化浊抑糖丸对2型糖尿病前期干预的临床观察[J].河南中医,2007:27(8):40-41
[90]范冠杰.专科专病名医临证经验丛书[M].糖尿病.北京:人民卫生出版社,2004:2.
[91]熊曼琪,朱章志.泻热逐瘀法治疗2型糖尿病的依据与作用探讨们[J].江西中医,1996,27(2):20.
[92]刘喜明.试论消渴病临床面貌与概念的变化[J].世界中西医结合杂志,2007,2(4):187-189.
[93]玉山江.糖尿病从热毒论治探要[J].新疆中医药,2000,18(4):7-8
[94]余胜利.陈氏降糖方治疗2型糖尿病临床观察[J].中国中医药科技.2007,16(5):374-375.
[95]鞠娟.“降糖饮”袋泡剂治疗2型糖尿病60例[J].现代中西医结合杂志.2007,16(34):5146-5147.
[96]蔡寒青,葛焕琦,张秀娟,等.天芪降糖胶囊治疗2型糖尿病60例临床观察[J].吉林大学学报.2003,29(5):669.
[97]刘瑞霞,吴红,徐东娟,等.左归丸化裁治疗糖尿病黎明现象30例[J].中国中医药信息杂志,2005,8(12).
[98]常风云,蔡冀民,郭喜军,等.消糖康治疗2型糖尿病胰岛素抵抗的临床研究[J].中华实用中西医杂志,2004,4(17):79-80.
[99]朴信映,仝小林.开郁清胃颗粒对2型糖尿病胰岛素敏感性的研究[J].中国中医药信息杂志,2003,10(10):11-13.
[100]石鹤峰.消渴Ⅱ号治疗2型糖尿病86例[J].光明中医,2002,17(99):46-47
[101]陈星.俞消丸治疗2型糖尿病60例[J].陕西中医,2003,24(10):908.
[102]陆智慧,王勇,毛秉环.中西医结合治疗胰岛素抵抗综合征34例临床观察[J].湖北中医杂志,2000,22(2):18-19.
[103]高书荣,卜建宏,朱良争.芪连汤与降糖药联合干预2型糖尿病胰岛素抵抗及对相关炎症细胞因子的影响[J].中国中西医结合杂志,2004,24(7):593-595.
[104]阎满堂.中西医结合治疗2型糖尿病45例临床观察[J].中医药导报,2005,11(7):24-25.
[105]李俊成,段宏宪,杨志霞.疏糖丹治疗2型糖尿病的临床观察[J].中医药学刊,2004,22(6):1001-1002.
[106]曹瑛.白虎人参汤加减与西药联合应用治疗2型糖尿病54例临床观察[J].中医药导报.2007,13(11):18-20.
[107]刘志群,许轶兰.参芪地黄汤治疗老年2型糖尿病62例[J].陕西中医.2006,25(9):929-930.
[108]郑仲华,曾庆明,李玲.参芪健脾汤联合二甲双胍治疗2型糖尿病胰岛素抵抗[J].中原医刊.2007,34(20):37-38.
[109]杨喜忠,孙静,康小刚,等.中医辨证分型治疗2型糖尿病疗效观察[J].现代护理,2007,2(13):487.
[110]王明山,马伟杰,杜翠红.地冬复胰胶囊配合西药治疗2型糖尿病临床观察[J].河北中医,2006,28(2):126-127.
[111]徐厚谦,中医药治疗糖尿病临床研究分析[J].中医研究,1997,13(2):29
[112]丁学屏.历代消渴名方治疗糖尿病的疗效述评[J].见林兰.中西医结合糖尿病研究进展[M].北京:海洋出版社,2000.79
[113]徐洁,钟丽娟.肉桂对2型糖尿病大鼠肝糖原、肌糖原的影响[J].中国中医药科技,2007,14(3):171-172.
[114]陈其明,谢明智.黄连及小檗碱降血糖作用的研究[J].药学学报,1986,21(6):401.
[115]胡发光,杜丙信,冯光.实用中西医结合杂志[J],1995,8(6):358.
[116]刘宝义,李英.黄芪对糖尿病肾脏保护作用[J].医学综述,2003,9(3):163.
[117]李先荣,董彦敏,程林忠,等.黄芪多糖冲剂治疗Ⅱ型糖尿病的临床研究[J].山西中医,1995,11(1):16.
[118]张宗明.针药结合治疗2型糖尿病的临床观察[J].湖北中医杂志,2007,3:35.
[119]李杭.耳穴贴压法辅助治疗2型糖尿病临床观察[J].实用中医内科杂志,2007,21(2):108.
[120]萧言生.糖尿病保健四大穴位[J].中华养生保健,2008,6:30-31.
[121]张世勤.推拿配合药物治疗2型糖尿病24例临床观察[J].吉林中医药,2008,28(3):177-178.
[1]李光伟,潘孝仁,Lilliojas等.检测人群胰岛素敏感性的一项新指标[J].中华内科杂志,1993:32(10):656
[2]郑莜萸主编.中药新药临床研究指导原则[M].中国中医药科技出版社,2002,233-238
[1]Pickup JC.Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes[J].Diabetes Care,2004,27(3):813-823
[2]Tanaka S,Isoda F,Ishlhara Y,et al.T lymphopaenia in relation to body mass index and TNF-alpha in human obesity:adequate weight reduction can be corrective[J].Clin Edocrinol,2001,54(3):347-354
[3]方芳,陈晓春,陈硕琪,等.老年糖尿病患者T淋巴细胞亚群的变化及临床意义[J].福建医科大学学报,2000,34(2):170-171
[4]Keane WF,Lyle PA.Recent advances in management of type 2 diabetes and nephropathy:lessons from the RENAAL study[J].Am J Kidney Dis,2003,41(3):22-25
[5]Mackay CR.T-cell memory:the connection between function,phenotype and migration pathways[J].Immunol Today,1991,12(6):189-192
[6]王妲.糖尿病与感染[J].中华内科杂志,1997,36(10):716-717
[7]Shau H,Gupta RK,Golub SH.Identification of a natural killer enhancing factor(NKEF) from human erythroid cells[J].Cell Immunol,1993,147(1):1-11
[8]盛宏光,金惠.2型糖尿病与流式细胞CD系列关系探讨[J].浙江预防医学,2001,13(7):53-54
[9]杨淑艳.2型糖尿病患者T淋巴细胞亚群测定及意义[J].白求恩军医学院学报,2007,5(4):234-235
[10]刘成玉,曲彦,谭润鸾.急性心肌梗塞病人血清sIL-2R、mIL-2R和T细胞亚群的变化[J].高血压杂志,1997,5(1):30-32
[11]沈泓,刘超,卜瑞芳等.2型糖尿病患者T细胞亚群、TNF-α及IL-10的相关性研究[J].天津医药,2007,35(11):823-825
[12]何萍,张学亮,张学光.参地糖脉宁对糖尿病大鼠免疫系统的影响[J].中国中医药信息杂志,2008,15(10):27-29
[13]李朝晖,苏琳,刘振清.参芪扶正注射液对糖尿病患者免疫功能的影响[J].中国医疗前沿,2008,3(15):22-23
[14]富宏,王学美,刘庚信.糖尿病中医辨证与T淋巴细胞亚群及NK细胞的相关性的研究[J].中华实用中西医杂志,2002,2(15):388-389
[15]刘芳,刘沈林,余江毅.维糖平对2型糖尿病免疫功能的影响[J].辽宁中医杂志,2002,29(12):756-757
[16]王健,管月帆.益寿永真液对老年2型糖尿病患者免疫功能的影响[J].浙江中医学院学报,2002,26(3):31-32
[17]齐敦禹,李兴海,王耀光等.太极拳运动对2型糖尿病患者免疫机能影响的研究[J].北京体育大学学报,2008,31(7):932-93
[18]李可.李可老中医急危重症疑难病经验专辑[M].山西.山西科学技术出版社,2002.45页.
[19]陈亦人.中医药发展新论[M].北京:中国科学技术出版社,1995.910页.
[20]刘力红.思考中医[M].第二版.广西:广西师范大学出版社,2003.458-460页.
[21]江剑.六经津液辨证论治消渴探析[J].实用中医内科杂志,2007,21(9):31-32.
[22]全世建,黎同明,刘妮.麻子仁丸治疗2型糖尿病便秘40例[J].陕西中医,2005,26(12):1357-1358.
[23]周英,蓝柳贵,封翠芸等.彭万年经方治疗糖尿病肾病经验举要[J].山东中医杂志,2006,25(11):773-774.
[24]赵进喜.《伤寒论》三阴三阳新解及其临床发挥[J].中医杂志,2007,48(3):208.赵进喜.三阴三阳辨证与糖尿病[J].中国中医药现代远程教育,2004,2(12):31
[25]魏丹蕾.试论厥阴病理论对糖尿病神经病变诊治的意义[J].广州中医药大学学报,2007,24(4):343-345.
[26]傅强.小柴胡汤加减治疗糖尿病酮症一例[J].环球中医药,2008,3:27.
[27]汪栋材,朱章志,蔡文就.熊曼琪运用经方治疗糖尿病经验[J].中国医药学报,2000,15(5):42-44.
[28]熊曼琪,林安钟,朱章志等.加味桃核承气汤对2型糖尿病大鼠胰岛素抵抗的影响[J].中国中西医结合杂志,1997,17(3):165-168.
[29]唐咸玉,周泉.糖尿病阳虚枢机不利探微[J].中医杂志,2006,47(12):886-887.
[30]李赛美.浅谈糖尿病及其并发症六经辨治思路[J].中华中医药杂志,2007,22(12):857-859.
[31]朱章志,唐咸玉.经方治疗糖尿病研究现状及其拓展运用探讨[J].华夏医药,2006,6:421-423.
[32]朱章志,任培华.扶正祛邪法方药对2型糖尿病患者胰岛素抵抗的影响[J].华夏医药,2007,1:12-13.
[33]唐咸玉,朱章志.温阳法在糖尿病治疗中的应用[J].实用中医内科杂志,2007,21(3):76-77
[34]张振忠.温阳利水法治疗消渴[J].陕西中医函授,1998,(2):13-14.
[35]唐咸玉,朱章志,陈利.温肾健脾、祛毒活血法对早期糖尿病肾病及IL-6、TNF -α的影响[J].中药新药与临床药理,2009,20(2):175-179.
[36]蔡永敏,徐学功.试论温阳法为治疗消渴病之大法[J].上海中医药杂志,2003,37(9):52-53.
[37]宁亚攻,彭仲杰.温阳活血治消渴一例报告[J].云南中医中药杂志,1996,17(3):74-74.
[38]刘立昌,桑树贤.桑景武运用真武汤治疗消渴病的经验[J].吉林中医药,1991,3:11.